Morning Overview on MSN
The Conversation: Review finds Alzheimer’s drugs show limited benefit
A new class of Alzheimer’s drugs promised to be the first treatments that actually slow the disease rather than just manage ...
New classification criteria for systemic sclerosis have just been published and are more sensitive than the 1980 criteria, enabling earlier identification and treatment of this disabling autoimmune ...
A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...
Morning Overview on MSN
Review finds GLP-1 weight-loss drugs may cut Alzheimer’s amyloid and tau
Drugs best known for helping people lose weight may also chip away at the proteins that define Alzheimer’s disease. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results